This is the conclusion of my series on Clínica 0-19, the cancer clinic where Drs. Alberto Siller and Alberto Garcia see patients with DIPG, a deadly brain tumor, whom they treat at Hospital Angeles in Monterrey Mexico with an unproven combination of intra-arterial chemotherapy with up to 11 drugs and a poorly defined dendritic cell immunotherapy. Some people have asked me: What’s the harm? In this concluding post, I attempt to answer that question.
Earlier this week, I discussed Clínica 0-19, a clinic “making DIPG history in Monterrey” whose doctors claim to be able to successfully treat the deadly brainstem cancer DIPG using intra-arterial chemotherapy and immunotherapy. This week, I discuss what I’ve learned since last week, specifically a lot more about just what it is that these doctors do, why it is scientifically dubious and unproven, and why I am becoming even more harsh in my assessment of this clinic, which shows every indication of being a predatory clinic selling an unproven treatment for a very high price.
Drs. Alberto Siller and Alberto Garcia run Clínica 0-19 in Monterrey, Mexico, which has become a magnet for patients with diffuse intrinsic pontine glioma (DIPG), a deadly brain cancer. Unfortunately, their treatment is an unproven combination of 11 chemotherapy drugs injected into an artery feeding the brainstem, plus an unknown and unproven “immunotherapy.” Of course it all costs $300,000 or more for a complete course of treatment, and the good doctors are “too busy to do clinical trials” or even publish their survival and recurrence statistics, despite having used this protocol for 20 years. I say: If it quacks like a duck…
Antivaccine pediatrician Dr. Bob Sears has been disciplined by the Medical Board of California, complete with a requirement for medical educations, ethics courses, and a practice monitor to make sure he doesn’t practice outside the standard of care. I wonder how his patients’ parents will like him now that he has to administer vaccines according to the CDC schedule.
In 2014, the Society for Integrative Oncology first published clinical guidelines for the care of breast cancer patients. Not surprisingly, SIO advocated “integrating” dubious therapies with oncology. Last week, the most influential oncology society, the American Society of Clinical Oncology (ASCO), endorsed a 2017 update to the SIO guidelines, thus endorsing the “integration” of quackery with oncology and paving the way for insurance coverage. The advance of quackademic medicine in oncology continues apace.
